Michelle Butterfield

Michelle Butterfield is a senior national online journalist with over 12 years of experience in journalism. She has covered crime and breaking news for The Calgary Herald and has worked as the Western Canada news correspondent and viral news editor for HuffPost Canada. Michelle has called Calgary home for the past 15 years but her heart belongs to Nova Scotia, where she loves to visit. When not busy with work, she volunteers in her community, advocates for young women living with breast cancer, runs a small fibre arts business and takes care of her two young children. Michelle has reported on various topics including the potential risks associated with Ozempic and Wegovy, the spread of flesh-eating bacteria disease in Japan, and updates on Kate Middleton's health. She is dedicated to providing accurate, timely information to her readers.

91%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

95%

Examples:

  • In the article about Kate Middleton's work update amid cancer battle, Michelle reports on the Princess's inability to return to public duties without being cleared by her medical team. This can be seen as a subtle nudge towards empathy and understanding for the royal who is undergoing chemotherapy.

Conflicts of Interest

95%

Examples:

  • In the article about Ozempic and Wegovy's potential risks, Michelle mentions the drugs reduce the risk of death by 20% in people who have had previous heart attacks and strokes.

Contradictions

92%

Examples:

  • In the article about Kate Middleton's work update amid cancer battle, Michelle reports that Princess Catherine will not return to public duties until cleared by her medical team.
  • In the article about Ozempic and Wegovy's potential risks, Michelle mentions that among those prescribed semaglutide for overweight or obesity, the rate of nonarteritic anterior ischemic optic neuropathy (NAION) was 6.7% versus 0.8% for those receiving other types of medications.
  • In the article about streptococcal toxic shock syndrome (STSS), Michelle states that as of June 2, Japan recorded 977 cases of STSS in 2023, surpassing last year's total of 941 cases within the first six months of 2024.

Deceptions

85%

Examples:

  • In the article about Kate Middleton's work update amid cancer battle, Michelle uses the term 'groom' instead of 'man' when describing an individual who was shot twice in the head at a wedding. This could be seen as a deceptive choice of words to downplay the severity of the crime.

Recent Articles

New Study Links Semaglutide Use to Increased Risk of Optic Neuropathy: 17 Diabetes and 20 Obesity Patients Developed NAION While Taking the Drug

New Study Links Semaglutide Use to Increased Risk of Optic Neuropathy: 17 Diabetes and 20 Obesity Patients Developed NAION While Taking the Drug

Broke On: Wednesday, 03 July 2024 Semaglutide use linked to increased risk of vision loss, study finds, prompting caution for Ozempic and Wegovy patients.
Japan's Surge in 'Flesh-Eating Bacteria' Cases: Over 1,000 Reported as of Mid-June 2024

Japan's Surge in 'Flesh-Eating Bacteria' Cases: Over 1,000 Reported as of Mid-June 2024

Broke On: Monday, 17 June 2024 Over 1,000 cases of Streptococcal Toxic Shock Syndrome (STSS), a rare and potentially deadly bacterial infection, have been reported in Japan as of mid-June 2024, surpassing the previous year's total. The Group A Streptococcus bacteria cause this severe infection, leading to symptoms like fever and organ failure within 24 to 48 hours. Practicing good hygiene and seeking medical attention for any signs of infection can prevent the progression to STSS. Diagnosis involves blood tests, and treatment includes antibiotics, fluid stabilization, and potentially surgery.
Princess Catherine of Wales Undergoing Chemotherapy for Unspecified Cancer: Continues Work with Royal Foundation Centre for Early Childhood

Princess Catherine of Wales Undergoing Chemotherapy for Unspecified Cancer: Continues Work with Royal Foundation Centre for Early Childhood

Broke On: Wednesday, 01 March 2023 Princess Catherine of Wales (Kate Middleton) is undergoing chemotherapy for cancer and has not yet returned to her royal duties. Announced on May 22, 2024, she continues to be briefed on her causes, including early childhood development through the Royal Foundation Centre for Early Childhood. Despite being out of the public eye since January 2024 due to abdominal surgery and a cancer diagnosis in March, she remains central to the center's work and will return when cleared by her medical team.